Functional vasoactive intestinal polypeptide (VIP)-system in salt glands of the Pekin duck.
In saltwater-acclimated ducks with fully specialized supraorbital salt glands, intracarotid application of acetylcholine (5 nmoles/min/kg b.w.) or porcine vasoactive intestinal polypeptide (pVIP) (240 pmoles/min/kg b.w.) induced secretion from the salt glands at threshold conditions of secretory activity. pVIP-like immunoreactivity could be localized in fibers of the postganglionic secretory nerve ramifying throughout the glandular parenchyma. Both middle-sized arterioles and secretory tubules were innervated, and pVIP-immunoreactive varicose fibers formed peritubular baskets around the basal region of secretory tubules indicating direct innervation of the secretory tissue. pVIP-specific staining could be abolished by preabsorption of the antiserum with peptide extracts of salt-gland tissue. Synthetic pVIP and endogenous VIP from salt glands of the duck co-eluted on the HPLC system, suggesting structural similarity of the peptides. Membrane-binding studies with radioiodinated pVIP revealed the presence of high-affinity binding sites in salt-gland tissue. Affinities of unlabeled pVIP analogues to compete for these binding sites were as follows: pVIP greater than PHI greater than pVIP antagonist greater than secretion greater than pVIP (10-28) greater than chicken VIP (16-28). Peptide extracts of salt glands had affinities similar to pVIP. Binding sites could be localized mainly at the apical end of the radially arranged secretory tubules, as demonstrated by receptor autoradiography. It is concluded that, in addition to the classical parasympathetic transmitter acetylcholine, VIP serves as neuromodulator/transmitter in cranial parasympathetic control of avian salt-gland secretion by acting on both the arteriolar network and the secretory tubules of the gland.
Gerstberger
R
R
Max-Planck-Institute of Physiological and Clinical Research, W.G. Kerckoff Institute, Bad Nauheim, Federal Republic of Germany.
D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D004372:Ducks; D005260:Female; D007261:Infusions, Intra-Arterial; D008297:Male; D011964:Receptors, Gastrointestinal Hormone / Q000378:metabolism; D018005:Receptors, Vasoactive Intestinal Peptide; D012491:Salt Gland / Q000187:drug effects*; D014660:Vasoactive Intestinal Peptide / Q000008:administration & dosage / Q000032:analysis / Q000378:metabolism / Q000494:pharmacology*
D011964:Receptors, Gastrointestinal Hormone; D018005:Receptors, Vasoactive Intestinal Peptide; D014660:Vasoactive Intestinal Peptide; D000109:Acetylcholine